Name: Foghorn Therapeutics Inc. (FHTX) Balance Sheet
Creator: FinSpry

Foghorn Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Foghorn Therapeutics Inc. (FHTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	55.45	80.34	52.21	154.29	92.80
Short-Term Investments	188.29	153.72	293.58	53.15	92.98
Cash & Short-Term Investments	243.75	234.06	345.80	154.29	185.77
Accounts Receivable	0.00	0.00	0.00	300.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.85	6.12	5.60	5.27	4.92
Total Current Assets	249.60	240.18	351.40	459.56	190.69
Non-Current Assets
Property, Plant & Equipment (Net)	32.61	42.91	49.40	56.08	62.33
Other Non-Current Assets	1.78	2.82	4.09	4.13	2.58
Total Non-Current Assets	34.38	45.74	53.48	60.21	0.00
Total Assets	283.98	285.92	404.88	519.77	255.59
Current Liabilities
Accounts Payable	3.79	6.26	5.41	13.38	3.68
Short-Term Debt	9.07	0.00	0.00	0.00	0.00
Accrued Liabilities	3.79	4.05	11.00	3.57	6.78
Deferred Revenue	45.61	34.55	32.82	28.32	2.02
Other Current Liabilities	8.53	0.04	4.74	5.60	2.39
Total Current Liabilities	66.99	58.44	55.21	48.69	18.85
Non-Current Liabilities
Long-Term Debt	28.06	36.56	45.54	51.34	19.65
Other Non-Current Liabilities	0.00	0.00	0.03	0.14	0.00
Total Non-Current Liabilities	262.52	304.67	349.57	374.21	0.00
Total Liabilities	329.51	363.11	404.77	422.90	109.41
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00
Retained Earnings	-558.18	-471.56	-373.14	-264.27	-162.94
Accumulated Other Comprehensive Income	0.14	-0.83	-3.99	-0.01	-0.01
Additional Paid-in Capital	512.52	395.20	377.23	361.13	0.00
Shares Outstanding	55.59	42.28	41.80	41.30	0.00
Total Stockholders' Equity	-45.53	-77.19	0.11	96.87	146.19
Total Liabilities & Equity	283.98	285.92	404.88	519.77	0.00